CSF3R and chronic neutrophilic leukemia: Pardanani et al. conducted a follow-up study to analyze CSF3R in a subset of WHO-defined patients, and their data were able to endorse the CSF3R T618I mutation as both a specific and sensitive genetic marker for the diagnosis of CNL [26].